GALXC
DEAD

Serial Number

87089769

Owner

Dicerna Pharmaceuticals, Inc.

Attorney

Glenn A. Gundersen

Filing Date

Jun 30, 2016

Add to watchlist:

No watchlists yet
View on USPTO

GALXC Trademark

Serial Number: 87089769

GALXC is a trademark filed by Dicerna Pharmaceuticals, Inc. on June 30, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Dicerna Pharmaceuticals, Inc. (33 trademarks)

Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

June 30, 2016

Registration Date

Not Registered

Published for Opposition

December 26, 2017

Goods & Services

research and development of anti-cancer drugs and anti-cancer preparations; research and development of pharmaceutical products

custom manufacture of oligonucleotides

Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; Biological compound in the form of a molecular complex that acts as a platform for the delivery of RNA-based drugs to biological cells; and drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 29, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 29, 2021 ABN6
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 25, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 25, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 25, 2021 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 22, 2020 EXRA
SOU EXTENSION 5 GRANTED
Aug 21, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 18, 2020 AITU
SOU EXTENSION 5 FILED
Aug 12, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 12, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2020 EXRA
SOU EXTENSION 4 GRANTED
Feb 13, 2020 EX4G
SOU EXTENSION 4 FILED
Feb 13, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 13, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2019 EXRA
SOU EXTENSION 3 GRANTED
Aug 12, 2019 EX3G
SOU EXTENSION 3 FILED
Aug 12, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 12, 2019 EEXT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 10, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 10, 2019 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 12, 2019 EXRA
SOU EXTENSION 2 GRANTED
Jan 10, 2019 EX2G
SOU EXTENSION 2 FILED
Jan 10, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 10, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 22, 2018 EXRA
SOU EXTENSION 1 GRANTED
Aug 20, 2018 EX1G
SOU EXTENSION 1 FILED
Aug 20, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 20, 2018 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 23, 2018 EWAF
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 20, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2017 NPUB
PUBLISHED FOR OPPOSITION
Dec 26, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 17, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 2, 2017 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 3, 2017 GNFN
FINAL REFUSAL E-MAILED
May 3, 2017 GNFR
FINAL REFUSAL WRITTEN
May 3, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 10, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 11, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 11, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 11, 2016 CNRT
ASSIGNED TO EXAMINER
Oct 11, 2016 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jul 15, 2016 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 15, 2016 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 5, 2016 NWOS
NEW APPLICATION ENTERED
Jul 4, 2016 NWAP